Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|June 15, 2016
Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/yChristopher J VandenBussche, Ashley Cimino-Mathews, Ben Ho Park, et al.
The American Journal of Surgical Pathology|April 15, 2015
Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costsChristopher J VandenBussche, Ashley Cimino-Mathews, Ben Ho Park, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Molecular Cell|November 17, 2023
Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrestReece Foy, Lisa Crozier, Aanchal U Pareri, et al.
American Journal of Clinical Pathology|March 18, 2011
Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobinGloria H Lewis, Andrea Proctor Subhawong, Hind Nassar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2014
Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activitiesHoai-Nghia Nguyen, Jr-Ming Yang, Yashar Afkari, et al.
The Biochemical Journal|October 18, 2012
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent mannerLihua Jin, Christin L Hanigan, Yu Wu, et al.
Endocrinology|October 14, 2017
Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer CellsZheqi Li, Kevin M Levine, Amir Bahreini, et al.
Breast Cancer Research and Treatment|March 16, 2018
A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencingKelly Kyker-Snowman, Bracha Erlanger Avigdor, Mansoor Nasim, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
HER2 missense mutations have distinct effects on oncogenic signaling and migrationDaniel J Zabransky, Christopher L Yankaskas, Rory L Cochran, et al.
Pageof 12